Plant Summary
Plant Information
TCMBank_ID: | TCMBANKHE001143 |
ID: | TCMBANKHE001143 |
植物拉丁名: |
|
功能与主治: | Treatment of: 1. Deficient yin of the liver and kidneys with hyperactive yang of the liver manifested as dizziness, vertigo, blurred vision or irritability. Dragon's bone (Longgu) is used with Oyster shell (Muli), Red ochre (Daizheshi) and White peony root (Baishao) in the formula Zhengan Xifeng Tang. 2. Seminal emissions due to deficient kidneys. Dragon's bone (Longgu) is used with Oyster shell (Muli), Flattened milkvetch seed (Shayuanzi) and Euryale seed (Qianshi). 3. Palpitations and insomnia. Dragon's bone (Longgu) is used with Oyster shell (Muli), Polygala root (Yuanzhi) and Wild jujube seed (Suanzaoren). 4. Leukorrhea due to deficient kidneys. Dragon's bone (Longgu) is used with Oyster shell (Muli), Dioscorea (Shanyao) and Cuttlefish bone (Wuzeigu). 5. Spontaneous sweating and night sweating. Dragon's bone (Longgu) is used with Oyster shell (Muli) and Schisandra fruit (Wuweizi)./Treatment of: 1. Deficient yin of the liver and kidneys with hyperactive yang of the liver manifested as dizziness, vertigo, blurred vision or irritability. Dragon's bone (Longgu) is used with Oyster shell (Muli), Red ochre (Daizheshi) and White peony roo |
药用植物名: | 煅龙骨 |
药味: | Mild; Sweet; Punkery |
经络: | Large Intestine; Liver; Heart; Kidney |
治疗类型: | 安神 |
TCM_ID_id: | 1796 |
TCMSP_id: | 229 |
植物对应的化合物
| 化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
|---|
| TCMBANKIN009139 | ca5(po4)3(oh) | ||||
| TCMBANKIN035904 | calcium phosphate | Calipharm T; 915772-79-1; beta tricalcium phosphate; Calcium phosphates; alpha-Tricalcium phosphate; KSC377C4P; UNII-279O8I0433 component QORWJWZARLRLPR-UHFFFAOYSA-H; AC1Q22HV; 1269629-39-1; Synthos; Phosphoric acid calcium(2+) salt (2:3); Calcium phosphate, Reagent for transient & stable DNA transfections; 1344-15-6; EINECS 233-283-6; JAX TCP; Posture (TN); Multifos; Calcium phosphate tribasic; 12167-74-7 (tri-calcium salt); DB11348; AC1LANN3; Tricalcium phosphate hydrate; Ca3(PO4)2; tricalciumphosphate; MolPort-003-925-398; Tricalcium diphosphate; Tribasic calcium phosphate; UNII-K4C08XP666; Posture (calcium supplement); Calcium phosphate, purum p.a., >=96.0% (calc. as Ca3(PO4)2, KT); Cerasorb; 97Z1WI3NDX; bone phosphate; CCRIS 3668; Natural whitlockite; Caswell No. 148; beta-tri-Calcium phosphate, puriss. p.a., >=95% beta-phase basis (sintered powder); Bonarka; Synthograft; Ca3O8P2; 21063-37-6; FEMA No. 3081; AC1L2NG3; Ceredex; Tertiary calcium phosphate; calcium phosphate basic; 7758-87-4; EPA Pesticide Chemical Code 076401; 123211-19-8; C08136; alpha-TCP; CTK2H7147; AKOS015833108; Calcium orthophosphate; Calcium Phosphate Tribasic, Powder, Reagent; TR-024786; FT-0645103; Tricafos P; 1314234-39-3; 10103-46-5; alpha-tri-Calcium phosphate, Reagent for transient & stable DNA transfections; Phosphoric acid, calcium salt (2:3); Phosphoric acid, calcium salt; Calcium phosphate; Calcium phosphate tribasic 500g; Bone ash; K4C08XP666; BONE POWDER, PURIFIED; TricOs; tricalcium bis(phosphate); Calcium orthophosphate, tri-(tert); beta-tri-Calcium phosphate, puriss. p.a., >=98% beta-phase basis (sintered Powder); CS-0013475; AI3-25607; alpha-tri-Calcium phosphate, puriss. p.a., >=75% alpha-phase basis (sinterted powder); 7757-93-9 (CaHPO4); CHEBI:9679; Calcium phosphate, tribasic; Tricalcium orthophosphate; OSferion; Vitoss; TRICALCIUM PHOSPHATE; tert-Calcium phosphate; 21063-37-6 (monetite); LS-2435; RTR-024786; tri-Calcium (ortho)phosphate; Calcigenol simple; tri-calcium phosphate; Tricalcium bis(orthophosphate); CHEMBL2106566; 1160697-13-1; Calcium phosphate (3:2); DTXSID1049803; Tricalcium phosphate hydrate, nanopowder, <200 nm particle size (BET); EC 231-840-8; D00938; Tricalcium bis(orthophosphate), with a fluorine content of less than 0,005 % by weight on the dry anhydrous product; beta-tri-Calcium phosphate, puriss. p.a., >=98% beta-phase basis (unsintered powder); Tricalcium phosphate (Ca3(PO4)2); Calcium tertiary phosphate; UNII-97Z1WI3NDX; Hydroxyapatite Powder; S338; Calcium phosphate (Ca3(PO4)2); beta-Tricalcium phosphate; KS-000011AF; beta-TCP; Ostram; beta-tri-Calcium phosphate, >=95% beta-phase basis (unsintered powder); calcium-phosphate; HSDB 879; QORWJWZARLRLPR-UHFFFAOYSA-H; EINECS 231-840-8; Phosphoric acid, calcium salt (1:?) | Ca5(PO4)3?OH or Ca3(PO4)2 | 310.2 g/mol | [O-]P(=O)([O-])[O-].[O-]P(=O)([O-])[O-].[Ca+2].[Ca+2].[Ca+2] |
植物对应的疾病
| 疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
|---|
植物对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 | 染色体位置 | Map_Location | 基因类型 |
|---|
滇ICP备16009434号-1 |
Dai SX Lab